KENNEWICK, Wash., Jan. 25, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Advanced Medical Isotopes Corporation’s (Pink Sheets:ADMD) Chief Executive Officer, William Stokes, is pleased to announce the licensing of United States Patent 6,680,993. Stokes said, “This patent is involved with the methods and processes directed to the preparation of Actinium-225 and daughters having high radiochemical and radionuclidic purity, which may be used for the preparation of radiopharmaceuticals for linkage to therapeutics such as those containing monoclonal antibodies, proteins, peptides, antisense, statin, natural products and hormones. Most importantly, the alpha-emitting radionuclide Actinium-225 and daughters can be used for both therapeutic and diagnostic purposes.”
